TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 184 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GERN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.3 7.3 6.8 5.4 6.6 3.6 1.2 1.2 1.1 0.3 3.3 7.6 2.8 1.7 3.6 2.4 2.7 1.3 1.2 36 6.2 1.1 1.1 0.5 0.3 1.4 0.6 0.2 77 184
-1.2 -1.6 -1.7 -3.7 -4.7 35 29 27 33 42 49 69 68 70 78 92 25 9.1 8.9 9.6 15 8.4 13 39 50 0.8 0.9 124 1.3 4.7
6.5 8.9 8.5 9.1 11 3.6 1.2 1.2 1.1 0.3 3.3 7.6 2.8 1.7 3.6 2.4 -22 -7.9 -7.7 27 -8.5 -7.4 -12 0.5 -50 1.4 0.6 0.2 76 179
14 15 16 21 24 29 32 26 30 35 41 55 54 58 62 69 51 23 21 18 18 11 13 52 51 86 96 125 104 74
3.2 3.1 3.8 5.6 9.3 9.6 5.4 5.8 7.1 8.8 9.4 16 16 14 18 24 20 16 17 18 19 19 19 21 26 30 44 69 146 159
19 20 21 30 37 39 37 31 37 38 51 70 70 72 80 93 72 39 37 36 37 30 32 73 27 115 139 194 249 233
-12 -11 -13 -21 -26 -35 -36 -30 -81 -38 -47 -63 -67 -70 -111 -96 -72 -39 -36 -0.6 -31 -29 -31 -73 -77 -114 -139 -194 -174 -54
0.4 0.0 0.9 0.0 12 1.0 0.8 0.7 0.7 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 3.7 6.9 8.3 19 33
-10 -9.1 -9.9 -44 -47 -30 -80 -34 -31 -37 -62 -70 -111 -97 -69 -38 -36 0.0 -30 -28 -27 -69 -76 -116 -142 -184 -175 -86
-1.5 -1.3 -1.8 26 20 7.1 -1.8 -0.3 44 -4.2 -16 -26 -5.9 -3.1 31 5.7 -0.6 0.1 0.0 0.0 1.1 1.3 4.1 -5.0 0.0 4.8 -0.9 0.0
-11 -9.6 -11 -46 -46 -42 -34 -30 -80 -34 -31 -37 -62 -70 -111 -97 -69 -38 -36 0.0 -30 -28 -27 -64 -76 -116 -142 -184 -175 -86
-11 -9.3 -11 -17 -22 -31 -31 -26 -32 -36 -47 -63 -60 -68 -110 -95 -68 -38 -36 0.8 -31 -29 -27 -72 -77 -112 -134 -175 -155 -52

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?